Dusa receives first approval of Levulan PDT for treatment of actinic keratoses Dec. 10, 1999 No Comments
Biogen reports phase II data for antipsoriatic agent and advances product to phase III Dec. 8, 1999 No Comments
Clinical trials with IDEC-114 begin following favorable safety and pharmacokinetic results in chimps Nov. 29, 1999 No Comments
Topical formulations of ABT-281 in development according to 1999 AAPS presentations Nov. 29, 1999 No Comments
Schering AG will handle marketing and sales of Levulan for Dusa; U.S. launch in sight Nov. 29, 1999 No Comments
Preliminary phase III results disappointing for Anogesic as anal fissure therapy Nov. 26, 1999 No Comments
RSS